IHEvsTMEDETF Comparison
iShares U.S. Pharmaceuticals ETF (IHE) and T. Rowe Price Health Care ETF (TMED) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. IHE is less expensive with a Total Expense Ratio (TER) of 0.38%, versus 0.44% for TMED. IHE is up 1.35% year-to-date (YTD) with +$81M in YTD flows. TMED performs worse with -0.2% YTD performance, and +$3M in YTD flows. Run a side-by-side ETF comparison of IHE and TMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
IHE vs TMED performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IHE TMED | +2.23%+7.12% | -1.25%-1.63% | +1.35%-0.20% | +30.25%n/a | +50.08%n/a | +55.43%n/a |
| Flows | IHE TMED | -$48M-$41K | -$25M+$3M | +$81M+$3M | +$212M- | +$312M- | +$345M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IHE TMED | +18.51%+20.92% | +17.96%n/a | +16.13%n/a | +15.99%n/a |
| Max drawdown | IHE TMED | -8.48%-9.37% | -9.18%n/a | -16.04%n/a | -16.12%n/a |
| Max drawdown duration | IHE TMED | 57d46d | 82dn/a | 210dn/a | 669dn/a |
IHE | TMED | |
Last sale 4/29/2026 at 1:30 PM | $84.82 | $29.19 |
| Previous close 04/28/2026 | $85.74 | $29.56 |
| Consolidated volume 04/28/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
IHE | TMED | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
IHE | TMED | |
|---|---|---|
| Last price | $84.82 | $29.19 |
| 1D performance | -1.07% | -1.28% |
| AuM | $937.71 M | $19.25 M |
| E/R | 0.38% | 0.44% |
IHE | TMED | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | iShares | T. Rowe Price |
| Benchmark | Dow Jones U.S. Select Pharmaceuticals Index | - |
| N° of holdings | 45 | 76 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | May 1, 2006 | June 11, 2025 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
